Zhejiang Ausun Pharmaceutical Co.,Ltd.(603229),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

603229 Zhejiang Ausun Pharmaceutical Co.,Ltd.

Closed 01-23 15:00:00

9.85

-0.02

-0.20%

High9.96	Low9.82	Vol10.01M
Open9.89	D1 Closing9.87	Amplitude1.42%
Mkt Cap8.18B	Tradable Cap8.18B	Total Shares830.00M
T/O98.70M	T/O Rate1.21%	Tradable Shares830.00M
P/B3.48	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"603229","market":"SH","secType":"STK","nameCN":"Zhejiang Ausun Pharmaceutical Co.,Ltd.","latestPrice":9.85,"timestamp":1769151601000,"preClose":9.87,"halted":0,"volume":10010007,"delay":0,"changeRate":-0.002,"floatShares":830000000,"shares":830000000,"eps":0.2227,"marketStatus":"Closed","change":-0.02,"latestTime":"01-23 15:00:00","open":9.89,"high":9.96,"low":9.82,"amount":98698400,"amplitude":0.0142,"askPrice":9.86,"askSize":174,"bidPrice":9.85,"bidSize":153,"shortable":0,"etf":0,"ttmEps":0.2227,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769391000000},"marketStatusCode":5,"adr":0,"adjPreClose":9.87,"symbolType":"stock","openAndCloseTimeList":[[1769131800000,1769139000000],[1769144400000,1769151600000]],"highLimit":10.86,"lowLimit":8.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":830297145,"isCdr":false,"pbRate":3.48,"roa":"--","peRate":44.229906,"roe":"8.86%","epsLYR":0.25,"committee":0.23995,"marketValue":8178000000,"turnoverRate":0.0121,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2026-01-26.","floatMarketCap":8178000000},"requestUrl":"/m/hq/s/603229/wiki","defaultTab":"wiki","newsList":[{"id":"2595250277","title":"Ausun Pharmaceutical Gets Nod to Market Two APIs; Shares Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595250277","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595250277?lang=en_us&edition=fundamental","pubTime":"2025-12-31 14:31","pubTimestamp":1767162696,"startTime":"0","endTime":"0","summary":"Zhejiang Ausun Pharmaceutical  received approval from China's National Medical Products Administration for the marketing of two active pharmaceutical ingredients , according to a Shanghai bourse filing on Wednesday.Both palbociclib API, used to treat breast cancer, and dapagliflozin API, intended to improve blood sugar control and reduce cardiovascular death risks, met the requirements for their registration.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"1113112774","title":"Zhejiang Ausun Pharmaceutical Elects Employee Representative Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1113112774","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113112774?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:21","pubTimestamp":1763475699,"startTime":"0","endTime":"0","summary":"On the evening of November 18, Zhejiang Ausun Pharmaceutical Co., Ltd. (603229) announced that the company held an employee representative assembly at the first-floor conference room of its new...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603229","BK0239"],"gpt_icon":0},{"id":"1164532644","title":"Zhejiang Ausun Pharmaceutical Announces No Share Repurchase in October","url":"https://stock-news.laohu8.com/highlight/detail?id=1164532644","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164532644?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:51","pubTimestamp":1762181464,"startTime":"0","endTime":"0","summary":"On the evening of November 3, Zhejiang Ausun Pharmaceutical Co., Ltd. (603229) disclosed in an announcement that the company did not conduct any share repurchases during October 2025.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2568645435","title":"Ausun Pharmaceutical Gets Registration Certificate for Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2568645435","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568645435?lang=en_us&edition=fundamental","pubTime":"2025-09-17 12:54","pubTimestamp":1758084846,"startTime":"0","endTime":"0","summary":"Zhejiang Ausun Pharmaceutical  will be able to produce and sell its imatinib mesylate tablets after receiving a drug registration certificate from the Chinese drug administration, according to a Shanghai bourse filing on Wednesday.The drug is used as a treatment for chronic myeloid leukemia and gastrointestinal stromal tumors.The pharmaceutical company invested 9.2 million yuan into the research and development of the drug.The company's shares rose over 1% during midday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"1187535653","title":"Zhejiang Ausun Pharmaceutical (603229.SH): Receives Drug Registration Certificate for Imatinib Mesylate Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1187535653","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187535653?lang=en_us&edition=fundamental","pubTime":"2025-09-16 16:16","pubTimestamp":1758010583,"startTime":"0","endTime":"0","summary":"Zhejiang Ausun Pharmaceutical Co.,Ltd. (603229.SH) announced that its wholly-owned subsidiary, Zhejiang Qizheng Pharmaceutical Co., Ltd. (\"Qizheng Pharmaceutical\"), has received a Drug Registration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603229","BK0239"],"gpt_icon":0},{"id":"1166057072","title":"Zhejiang Ausun Pharmaceutical Co.,Ltd. (603229.SH) Reports Semi-Annual Results with Net Profit of 169 Million Yuan, Down 5.83% Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1166057072","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166057072?lang=en_us&edition=fundamental","pubTime":"2025-08-28 15:50","pubTimestamp":1756367424,"startTime":"0","endTime":"0","summary":"Zhejiang Ausun Pharmaceutical Co.,Ltd. (603229.SH) disclosed its 2025 semi-annual report. During the reporting period, the company achieved revenue of 482 million yuan, representing a year-over-year...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","603229"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-05-09","address":"浙江省台州市临海市化学原料药基地临海园区东海第四大道5号","stockEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":0.0293},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0325},{"period":"1year","weight":0.1895},{"period":"ytd","weight":-0.0071}],"companyName":"浙江奥翔药业股份有限公司","boardCode":"AI0027","perCapita":"25948股","boardName":"医药制造业","registeredCapital":"83029万元","compareEarnings":[{"period":"1week","weight":0.0083},{"period":"1month","weight":0.0495},{"period":"3month","weight":0.047},{"period":"6month","weight":0.151},{"period":"1year","weight":0.2805},{"period":"ytd","weight":0.0422}],"survey":"　　浙江奥翔药业股份有限公司的主营业务是制剂、特色原料药及医药中间体的研发、生产与销售，以及为客户提供定制生产和研发业务。公司的主要产品是制剂、特色原料药、医药中间体。","serverTime":1769260195064,"listedPrice":7.81,"stockholders":"31998人(较上一季度增加5.64%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zhejiang Ausun Pharmaceutical Co.,Ltd.(603229),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zhejiang Ausun Pharmaceutical Co.,Ltd.(603229) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zhejiang Ausun Pharmaceutical Co.,Ltd.,603229,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票老虎,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票老虎国际,Zhejiang Ausun Pharmaceutical Co.,Ltd.行情,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票行情,Zhejiang Ausun Pharmaceutical Co.,Ltd.股价,Zhejiang Ausun Pharmaceutical Co.,Ltd.股市,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票价格,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票交易,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票购买,Zhejiang Ausun Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zhejiang Ausun Pharmaceutical Co.,Ltd.(603229),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zhejiang Ausun Pharmaceutical Co.,Ltd.(603229) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction